Hyperlipidaemia Flashcards
Aetiology of hyperlipidaemia
Primary:
- Familial hypercholesterolaemia
- Polygenic hypercholesterolaemia
- Familial hyper𝛼lipoproteinaemia
- Phytosterolaemia
Secondary:
Hormonal: Hypothyroidism, pregnancy, exogenous sex-hormones
Metabolic: Diabetes, liver disease, gout, obesity, partial lipodystorphy
Renal: nephrotic syndrome, renal failure
Alcohol
iatrogenic: anti-HTN, immunosuppressants
Signs of hyperlipidaemia on examination
Tendon xanthomata
Corneal arcus
Xanthelasma
Eruptive xanthoma
Ankle xanthomata
Investigations for hyperlipidaemia
Full lipid profile
- Total cholesterol >7.5
- non-HDL-C
- HDL-C
- Triglyceride levels >2.3
± fasting lipid profile
LFTs: for statins
CK: for statin SE
Broome criteria for genetic testing (takes months)
U&Es/renal function
HbA1c
TFTs
Lipoprotein A
Management for established hyperlipidaemia
Lifestyle
- Diet: avoid Red meat, dairy (cheese, butter, yoghurt, milk), fried foods, low carb diets
- Exercise: At least 150 minutes aerobic exercise a week
- Stop smoking
Statins (HMG-coA) - lowers LDL by 40%
Other
- Omacor (?)
- Ezetimibe - lowers by 20%, can ADD to statin
- Bempedoic acid - acts on the lipid pathway and does not have the SE of aches and pains BUT risk of gout
Primary prevention regimen for hyperlipidaemia
Done if QRISK >10% + 25-84 OR T1DM, CKD, familial
- Lifestyle
- Medication
First line: low-dose statin e.g. atorvastatin 20mg OD
Second: ezetimibe ± bempedoic acid
Third: evolocumab/alirocumab
Review annually
LFTs before statin, within 3 months of starting and at 12 months
Secondary prevention regimen for hyperlipidaemia
For those who have CVD/CV event
First line: high intensity statin e.g. atorvastatin 80mg once a day
Check LFTs within 3 months of starting treatment and again at 12 months
Complications of statins
Myopathy (incidence 5 cases per 100,000 person years)
Rhabdomyolysis (incidence 1.6 cases per 100,000 person years)
Complications and prognosis of hyperlipidaemia
Cardiovascular disease
Stroke and TIA
Peripheral arterial disease
Vast majority of patients do well with statin therapy without adverse events
Cases of myopathy and any muscle-related symptoms associated with statin therapy generally resolve after discontinuation of treatment.